Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LIMCH1 antisense RNA 1 (LIMCH1-AS1) is a long non-coding RNA transcribed in the antisense direction from the LIMCH1 locus. Antisense lncRNAs like LIMCH1-AS1 typically regulate the expression of their corresponding sense gene (in this case, LIMCH1) through diverse molecular mechanisms, including RNA-RNA duplex formation, modulation of mRNA stability, recruitment of chromatin modifiers, or acting as molecular sponges for microRNAs[2]. While many antisense lncRNAs play roles in cancer progression by influencing cell proliferation, invasion, and gene expression, LIMCH1-AS1's specific functions, disease associations, or therapeutic relevance have not yet been well-characterized in the current biomedical literature[4][2]. If your application requires well-characterized targets, note that LIMCH1-AS1 is a valid, recognizable lncRNA entity, but there is currently no evidence that it serves as a drug target or diagnostic biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LIMCH1 antisense RNA 1 (LIMCH1-AS1).